Clinical Trials Directory

Trials / Completed

CompletedNCT02912156

Pharmacokinetics of Two Different Formulation of Voriconazole

A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of Two Different Formulation of Voriconazole 200mg Tablets in Healthy Adult Subjects

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Yung Shin Pharm. Ind. Co., Ltd. · Industry
Sex
All
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of Two Different Formulation of Voriconazole 200 mg Tablets in Healthy Adult Subjects.

Conditions

Interventions

TypeNameDescription
DRUGVaway FC Tablets 200mg (Voriconazole)
DRUGVFEND FC Tablets 200mg (Voriconazole)

Timeline

Start date
2016-06-01
Primary completion
2016-07-01
Completion
2016-08-01
First posted
2016-09-23
Last updated
2016-09-23

Source: ClinicalTrials.gov record NCT02912156. Inclusion in this directory is not an endorsement.